Tubule-derived CCN1 drives renal repair via αvβ5-STAT6-ARG1-dependent reprogramming of macrophages
Macrophages play a critical role in injury and repair following acute kidney injury (AKI), but their regulatory mechanisms remain incompletely understood. Cellular communication network factor 1 (CCN1), a secreted matricellular protein and early biomarker of AKI, may regulate macrophage function during kidney injury. In this study, we first investigated CCN1's interaction with macrophages in a murine model of ischemia-reperfusion (I/R)-induced AKI. The role of CCN1 was further investigated using recombinant protein administration, a renal tubular epithelial cell (RTEC)-specific CCN1 knockdown mouse model via adeno-associated virus, and in vitro studies with bone marrow-derived macrophages (BMDMs). We found that in response to injury, RTECs upregulated and secreted CCN1, which colocalized with infiltrating F4/80<sup>+</sup> macrophages. RTEC-specific CCN1 knockdown exacerbated renal injury and reduced macrophage infiltration, as confirmed by H&E, KIM-1 and F4/80 staining. Transcriptomic profiling of kidney tissues revealed that CCN1 expression was associated with immune cell infiltration, particularly macrophages, while RNA-seq analysis of BMDMs demonstrated that CCN1 promoted pro-repair arginase1 (Arg1)<sup>+</sup> macrophage differentiation and activated the STAT6 signaling pathway. BayesPrism deconvolution further confirmed the enrichment of Arg1<sup>hi</sup> macrophages following CCN1 treatment. Co-immunoprecipitation coupled with mass spectrometry identified integrin α<sub>v</sub>β<sub>5</sub> as a direct CCN1-binding partner mediating STAT6/ARG1 activation. Functionally, CCN1-treated macrophages enhanced RTECs' proliferation in vitro and in vivo, an effect abolished by ARG1 inhibition or macrophage depletion. In conclusion, CCN1 regulates macrophages via the α<sub>v</sub>β<sub>5</sub>-STAT6-ARG1 axis to promote tubular epithelial proliferation and improve kidney function in I/R-AKI, highlighting a novel tubular-immune communication pathway and potential therapeutic targets for ischemic AKI.
Authors
- Zhuo Song (ORCID: https://orcid.org/0000-0001-8711-7372)
- Xiaofei Man
- Lin Che (ORCID: https://orcid.org/0009-0005-2619-9382)
- Yan Xu (ORCID: https://orcid.org/0000-0002-9726-3186)
- Ningxin Zhang (ORCID: https://orcid.org/0000-0002-6258-9047)
- Yanlu Xin
- Ruizhe Zhao (ORCID: https://orcid.org/0000-0003-2891-4130)
- Minghao Gu (ORCID: https://orcid.org/0000-0002-1666-4691)
- Hang Liu (ORCID: https://orcid.org/0000-0002-6365-7435)
- Chenyu Li (ORCID: https://orcid.org/0000-0002-5402-584X)
- Yanfei Wang (ORCID: https://orcid.org/0000-0003-0300-0287)
- Tianyang Li (ORCID: https://orcid.org/0000-0001-6477-2059)
- Lingyu Xu
- Guan Chen (ORCID: https://orcid.org/0000-0001-8834-039X)
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
- University of Pennsylvania (US)
Publication Details
- Journal
- Cell Death and Disease
- Published
- 2025-12-21
- DOI
- https://doi.org/10.1038/s41419-025-08340-2
- Primary Topic
- Connective Tissue Growth Factor Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Qingdao Key Health Discipline Development Fund
- National Natural Science Foundation of China